Endotronix
Woodridge, US · Delaware corporation · 6 known investors
Find your way into Endotronix
6 people in our graph share verified history with the Endotronix team — schools, employers, funds. One of them is your warm intro.
Paul LaVioletteunlockedknows Harry Rowland · together at Endotronix
×5knows the team · via Endotronix
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.
Founders & leadership
HR
Harry RowlandinCo-founderHarry Rowland holds a PhD in mechanical engineering from Georgia Institute of Technology and degrees in mechanical engineering and economics from UC Santa Barbara. He co-founded Endotronix, where he served as CEO and led the development of the Cordella pulmonary artery pressure sensor and heart failure monitoring system through FDA approval and acquisition by Edwards Lifesciences in 2024.
AI
Anthony I NunezinCo-founder
AA
Anthony A. NunezinCo-founder
AN
Anthony NunezinCo-founder
Board
JJ
Jonathan JonasBoard director
RS
Raymond S. Barrett, Jr.Board director
SR
Sam R. LenoBoard director
LA
Leslie A. SaxonBoard director
JJ
James J. HummerBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$113.1M disclosed across 5 rounds · 2014–2018
▶$69.3MraisedDec 2020 · 38 investors · Other Health CareRule 506(b)
▶$69.3MraisedDec 2020 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Fouad AzzamDirector
- John FlavinExecutive Officer
- Robert ZieserlDirector
- Paul LaVioletteDirector
- Marc GoldbergDirector
- Gerry BrunkDirector
- James HummerDirector
- Jennifer McMahonDirector
- Harry RowlandExecutive Officer, Director
- Offering amount
- $90.8M
- Amount sold
- $69.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.1MraisedFeb 2018 · 52 investors · Other Health CareRule 506(b)
▶$37.1MraisedFeb 2018 · 52 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul LaVioletteDirector
- Gerry BrunkDirector
- Robert ZieserlDirector
- Harry RowlandExecutive Officer, Director
- Kent ElmerExecutive Officer
- Marc GoldbergDirector
- James HummerDirector
- Jennifer McMahonDirector
- Offering amount
- $37.1M
- Amount sold
- $37.1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedDec 2015 · 25 investors · Other Health CareRule 506(b)
▶$3MraisedDec 2015 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan JonasDirector
- Sam R. LenoDirector
- Harry RowlandExecutive Officer, Director
- Leslie SaxonDirector
- Anthony I NunezExecutive Officer, Director
- Raymond S. Barrett, Jr.Director
- James J. HummerDirector
- Offering amount
- $3.5M
- Amount sold
- $3M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedFeb 2015 · 10 investors · Other Health CareRule 506(b)
▶$2.2MraisedFeb 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan JonasDirector
- Harry RowlandExecutive Officer, Director
- Raymond S. Barrett, Jr.Director
- Anthony I NunezExecutive Officer, Director
- Sam R. LenoDirector
- Leslie A. SaxonDirector
- James J. HummerDirector
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedApr 2014 · 4 investors · Other Health CareRule 506(b)
▶$1.6MraisedApr 2014 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Harry RowlandExecutive Officer, Director
- Sam R. LenoDirector
- James J. HummerDirector
- Leslie A. SaxonDirector
- Anthony A. NunezExecutive Officer, Director
- Raymond S. Barrett, Jr.Director
- Offering amount
- $3M
- Amount sold
- $1.6M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Rf Surgical44 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards Lifesciences31 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Boston Scientific31 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies competing with Endotronix for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Endotronix do?
- Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.
- Who founded Endotronix?
- Endotronix was founded by Harry Rowland, Anthony I Nunez, Anthony A. Nunez, Anthony Nunez.
- Who are Endotronix's investors?
- Endotronix's investors include Bioventures Investors, Jumpstart Ventures, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors.
- How much funding has Endotronix raised?
- Endotronix has disclosed $113.1M raised across 5 rounds.
- Where is Endotronix headquartered?
- Endotronix is headquartered in Woodridge, US.